To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

The overall response rate (ORR) is 35%; this increases to 42% when including unconfirmed responses Narmafotinib continues to be well tolerated by patients with the adverse effect profile of the ...

Please provide your email address to receive an email when new articles are posted on . In 2020, the global lifetime risk for developing and dying from gastrointestinal cancers was 8.2% and 6.17%.

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...

A study at two US medical centers found that patients with brain metastases from gastrointestinal (GI) cancers had significantly worse overall survival and intracranial progression-free survival (PFS) ...

Developing slowly over months to years, feline small cell gastrointestinal (GI) lymphoma can be difficult to detect. 1 With this type of cancer resembling many of the common digestive issues cats ...